[1] |
Chitale SV, Scott-Barrett S, Ho ETS, et al. The management of ureteric obstruction secondary to malignant pelvic disease[J]. Clin Radiol, 2002, 57(12): 1118-1121.
|
[2] |
Song Y, Fei X, Song Y. Percutaneous nephrostomy versus indwelling ureteral stent in the management of gynecological malignancies[J]. Int J Gynecol Cancer, 2012, 22(4): 697-702.
|
[3] |
Ganatra Anjali M, Loughlin Kevin R. The management of malignant ureteral obstruction treated with ureteral stents[J]. J Urol, 2005, 174(6): 2125-2128.
|
[4] |
Ishioka J, Kageyama Y, Inoue M, et al. Prognostic model for predicting survival after palliative urinary diversion for ureteral obstruction: analysis of 140 cases[J]. J Urol, 2008, 180(2): 618-621.
|
[5] |
Wong LM, Cleeve LK,Milner AD, et al. Malignant ureteral obstruction: Outcomes after intervention. Have things changed? [J]. Urol, 2007, 178(1):178-183; discussion 183.
|
[6] |
Izumi K, Mizokami A, Maeda Y, et al. Current outcome of patients with ureteral stents for the management of malignant ureteral obstruction[J]. J Urol, 2011, 185(2):556-61.
|
[7] |
沈瑞林, 蔡松良. 急性上尿路梗阻性无尿的治疗方法探讨(附58例报告)[J].临床泌尿外科杂志, 2007, 22(3): 192-194.
|
[8] |
Van der Meer RW, Weltings S, van Erkel AR, et al. Antegrade Ureteral Stenting is a Good Alternative for the Retrograde Approach[J]. Curr Urol, 2017, 10(2): 87-91.
|
[9] |
Yossepowitch O, Lifshitz DA, Dekel Y, et al. Predicting the success of retrograde stenting for managing ureteral obstruction[J]. Urol, 2001, 166(5): 1746-1749.
|
[10] |
Lu DS, Papanicolaou N, Girard M, et al. Percutaneous internal ureteral stent placement:review of technical issues and solutions in 50 consecutive cases[J]. Clin Radiol, 1994, 49(4): 256-61.
|
[11] |
Rao A R, Alleemudder A, Mukerji G, et al. Extra-anatomical complications of antegrade double-J insertion[J]. Indian J Urol, 2011, 27(1): 19-24.
|
[12] |
Yossepowitch O, Lifshitz DA, Dekel Y et al. Predicting the success of retrograde stenting for managing ureteral obstruction[J]. J Urol, 2001,166(5): 1746-1749.
|
[13] |
Ganatra AM, Loughlin KR. The management of malignant ureteral obstruction treated with ureteral stents[J]. J Urol, 2005, 174(6): 2125-2128.
|
[14] |
Vogt B,Desgrippes A, Desfemmes FN. Changing the double-pigtail stent by a new suture stent to improve patient's quality of life:a prospective study[J]. World J Urol, 2015, 33(8): 1061-1068.
|
[15] |
Liatsikos EN, Karnabatidis D, Kagadis GC, et al. Application of paclitaxel-eluting metal mesh stents within the pig ureter: an experimental study[J]. Eur Urol, 2007, 51(1): 217-223.
|
[16] |
Varnavas Michalis, Bolgeri Marco, Mukhtar Saheel. The Role of Tandem Double-J Ureteral Stents in the Management of Malignant Ureteral Obstruction[J]. J Endourol, 2016, 30(4): 465-468.
|
[17] |
Elsamra SE, Motato H, Moreria D,et al. Tandem ureteral stents for the decompression of malignant and benign obstructive uropathy[J]. J Endourol, 2013, 27(10): 1297-302.
|
[18] |
Liu Kao-Lang, Lee Bo-Ching, Ye Jian-De, et al. Comparison of single and tandem ureteral stenting for malignant ureteral obstruction: a prospective study of 104 patients[J]. Eur Radiol, 2019, 29(2): 628-635.
|
[19] |
马波, 江春强, 钟文文, 等. Resonance金属输尿管双J管在恶性疾病相关性输尿管梗阻中的应用[J/CD]. 中华腔镜泌尿外科杂志(电子版), 2018, 12(4): 248-253.
|
[20] |
Liatsikos E, Kallidonis P,Kyriazis I,et al. Ureteral obstruction:is the full metallic double-pigtail stent the way to go? [J]. Eur Urol, 2010, 57(3): 480-486.
|
[21] |
陈亮, 沈柏华, 陈戈明, 等. 金属支架管在解除恶性输尿管梗阻中的疗效评价[J]. 国际泌尿系统杂志, 2016, 36(6): 869-872.
|
[22] |
刘可, 肖春雷, 马潞林. 金属输尿管支架置入治疗肿瘤性输尿管梗阻的疗效和初步经验[J].中华泌尿外科杂志, 2015, 36(10): 757-760.
|
[23] |
Taylor ER, Benson AD, Schwartz BF. Cost analysis of metallic ureteral stents with 12 months of follow-up[J]. J Endourol, 2012, 26(7): 917-921.
|
[24] |
Lugmayr H, Pauer W. Self-expanding metal stents for palliative treatment of malignant ureteral obstruction[J]. AJR Am Roentgenol, 1992, 159(5): 1091-1094.
|
[25] |
Flueckiger F, Lammer J, Klein GE, et al. Malignant ureteral obstruction: preliminary results of treatment with metallic self-expandable stents[J]. Radiology, 1993, 186(1): 169-173.
|
[26] |
Reinberg Y, Ferral H, Gonzalez R, et al. Intraureteral metallic self-expanding endoprosthesis (Wallstent) in the treatment of difficult ureteral strictures[J]. J Urol, 1994, 151(6): 1619-1622.
|
[27] |
Barbalias GA, Liatsikos EN, Kalogeropoulou C, et al. Metallic stents in gynecologic cancer:an approach to treat extrinsic ureteral obstruction[J]. Eur Urol, 2000, 38(1): 35-40.
|
[28] |
Tekin MI, Aytekin C, Aygün C, et al. Covered metallic ureteral stent in the management of malignant ureteral obstruction:preliminary results[J]. Urology, 2001, 58(6): 919-923.
|
[29] |
Trueba Arguinarena FJ, del Busto EF. Self-expanding polytetrafluoroethylene covered nitinol stents for the treatment of ureteral stenosis:preliminary report[J]. J Urol, 2004, 172(2): 620-623.
|
[30] |
Chung KJ, Park BH, Park B, et al. Efficacy and safety of a novel, double-layered, coated, self-expandable metallic mesh stent (Uventa™) in malignant ureteral obstructions[J]. J Endourol, 2013, 27(7): 930-935.
|
[31] |
Moskovitz B, Halachmi S, Nativ O. A new self-expanding, large-caliber ureteral stent: results of a multicenter experience[J]. J Endourol, 2012, 26(11): 1523-1527.
|
[32] |
Silagy A, Merrett C, Agarwal D. Initial experience with Allium™ stent in the management of bulbar urethral stricture[J].Transl Androl Urol,2017, 6(Suppl 2): S88-S91.
|
[33] |
Agrawal S, Brown CT, Bellamy EA, Kulkarni R. The thermo-expandable metallic ureteric stent: an 11-year follow-up[J]. BJU Int, 2009, 103(3): 372-376.
|
[34] |
Zaman F, Poullis C, Bach C, et al. Use of a segmental thermoexpandable metal alloy stent in the management of malignant ureteric obstruction:a single centre experience in the UK[J]. Urol Int, 2011, 87(4): 405-410.
|
[35] |
Kallidonis Panagiotis, Kotsiris Dimitrios, Sanguedolce, et al. The effectiveness of ureteric metal stents in malignant ureteric obstructions: A systematic review[J]. Arab J Urol, 2017, 15(4): 280-288.
|
[36] |
Matsuura H, Arase S, Hori Y. Ureteral stents for malignant extrinsic ureteral obstruction:outcomes and factors predicting stent failure[J]. Int J Clin Oncol, 2018, 24(3): 306-312.
|
[37] |
Ohtaka M, Kawahara T, Takamoto D, et al. Gastrointestinal cancer and bilateral hydronephrosis resulted in a high risk of ureteral stent failure[J]. BMC Urol, 2018, 18(1): 35.
|
[38] |
Kang Q, Jiang F, Yu Y, Yang B, et al. Application of metallic ureteral stents in gynecological malignancies:a literature review[J].Minimally Invasive Therapy & Allied Technologies, 2019, 29(1): 1-9.
|
[39] |
Fiuk J, Bao Y, Calleary JG, et al. The use of internal stents in chronic ureteral obstruction[J]. J Urol, 2015, 193(4): 1092-1100.
|
[40] |
Lee C,Kuskowski M, Premoli J, et al. Randomized evaluation of Ureteral Stents using validated Symptom Questionnaire.[J]. J Endourol, 2005,19(8): 990-993.
|
[41] |
屠卫超, 潘隽玮, 王大伟, 等. 托特罗定联合坦索罗辛在改善输尿管支架管相关症状中的作用 [J/CD]. 中华腔镜泌尿外科杂志(电子版), 2019, 13(3): 187-190.
|
[42] |
Betschart P, Schmid HP, Abt D. Problems with ureteral stents-a never-ending story[J]. Praxis (Bern 1994), 2016, 105(6): 323-328.
|
[43] |
Lange D, Bidnur S, Hoag N, et al. Ureteral stent-associated complications--where we are and where we are going[J]. Nat Rev Urol, 2015, 12(1): 17-25.
|
[44] |
Elsamra SE, Leavitt DA, Motato HA, et al. Stenting for malignant ureteral obstruction: Tandem, metal or metal-mesh stents[J]. Int J Urol, 2015, 22(7): 629-636.
|
[45] |
Bahouth Z, Moskovitz B, Halachmi S, Nativ O. Allium Stents: A Novel Solution for the Management of Upper and Lower Urinary Tract Strictures[J]. Rambam Maimonides Med J, 2017: 8(4): e0043.
|
[46] |
Kim KS, Choi S, Choi YS, et al. Comparison of efficacy and safety between a segmental thermo-expandable metal alloy spiral stent (Memokath 051) and a self-expandable covered metallic stent (UVENTA) in the management of ureteral obstructions[J]. Laparoendosc Adv Surg Tech A,2014, 24(8): 550-555.
|